Fluctuation of the volume of distribution of amikacin and its effect on once-daily dosage and clearance in a seriously ill patient

Intensive Care Medicine

Volumn 22, Issue 5, 1996, Pages 443-446

  Botha, F J H ^a   Van Der Bijl, P ^b   Seifart, H I ^a   Parkin, D P ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Amikacin; Clearance; Intensive care; Monitoring procedures; Once daily treatment; Volume of distribution

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLOOD SAMPLING; CASE REPORT; CLINICAL FEATURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; FLUID THERAPY; HEAD INJURY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; RESPIRATORY TRACT INFECTION;

ADULT; AMIKACIN; ANTI-BACTERIAL AGENTS; CRANIOCEREBRAL TRAUMA; DRUG MONITORING; EXTRACELLULAR SPACE; FLUID THERAPY; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 0029882533     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01712162     Document Type: Article

References (9)

1. Giamarellou H, Yiallouros K, Petrikkos G, Moschovakis E, Vavouraki H, Voutsinas D, Sfikakis, P (1991) Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic gram-negative infections. J Antimicrob Chemother 27 [Suppl C]: 73-79
2. Marik PE, Havlik I, Monteagudo FSE, Lipman J (1991) The pharmacokinetics of amikacin in critically ill adult and paediatric patients: comparison of once-versus twice-daily dosing regimens. J Antimicrob Chemother 27 [Suppl C]: 81-89
3. Nordström L, Ringberg H, Cronberg S, Tjernström O, Walder, M (1990) Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity? J Antimicrob Chemother 25: 159-173
4. Laveso LA, Davis RL (1994) Two- versus three-sample method for estimating gentamicin pharmacokinetic values. Am J Hosp Pharm 51: 1021-1024
5. Gibaldi M, Perrier D (1982) Pharmacokinetics. In: Swarbrick J (ed) Pharmacokinetics. Dekker, New York Basel, pp 319-354
6. Van der Bijl P, De Stadler DR (1994) Amikacin determination using four different instruments. J Antimicrob Chemother 33: 672-673
7. Benet LZ, Williams RL (1990) Design and optimization of dosage regimens; pharmacokinetic data. In: Goodman AG, Rall TW, Nies AS, Taylor P (eds) Goodman and Gilman's the pharmacological basis of therapeutics 8th edn. Pergamon Press, New York Oxford, p 1656
8. Beaucaire G, Leroy O, Beuscart C, Karp P, Chidiac C, Caillaux M (1991) Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections. J Antimicrob Chemother 27 [Snppl C]: 91-103
9. Barclay ML, Begg EJ, Hickling KG (1994) What is the evidence for once-daily aminoglycoside therapy? Clin Pharmacokinet 27: 32-48